|
Atomistry » Manganese » PDB 5hzz-5jpf » 5ji6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Manganese » PDB 5hzz-5jpf » 5ji6 » |
Manganese in PDB 5ji6: Potent, Reversible METAP2 Inhibitors Via FbddEnzymatic activity of Potent, Reversible METAP2 Inhibitors Via Fbdd
All present enzymatic activity of Potent, Reversible METAP2 Inhibitors Via Fbdd:
3.4.11.18; Protein crystallography data
The structure of Potent, Reversible METAP2 Inhibitors Via Fbdd, PDB code: 5ji6
was solved by
D.R.Dougan,
J.D.Lawson,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 5ji6:
The structure of Potent, Reversible METAP2 Inhibitors Via Fbdd also contains other interesting chemical elements:
Manganese Binding Sites:
The binding sites of Manganese atom in the Potent, Reversible METAP2 Inhibitors Via Fbdd
(pdb code 5ji6). This binding sites where shown within
5.0 Angstroms radius around Manganese atom.
In total 2 binding sites of Manganese where determined in the Potent, Reversible METAP2 Inhibitors Via Fbdd, PDB code: 5ji6: Jump to Manganese binding site number: 1; 2; Manganese binding site 1 out of 2 in 5ji6Go back to Manganese Binding Sites List in 5ji6
Manganese binding site 1 out
of 2 in the Potent, Reversible METAP2 Inhibitors Via Fbdd
Mono view Stereo pair view
Manganese binding site 2 out of 2 in 5ji6Go back to Manganese Binding Sites List in 5ji6
Manganese binding site 2 out
of 2 in the Potent, Reversible METAP2 Inhibitors Via Fbdd
Mono view Stereo pair view
Reference:
Z.Cheruvallath,
M.Tang,
C.Mcbride,
M.Komandla,
J.Miura,
T.Ton-Nu,
P.Erikson,
J.Feng,
P.Farrell,
J.D.Lawson,
D.Vanderpool,
Y.Wu,
D.R.Dougan,
A.Plonowski,
C.Holub,
C.Larson.
Discovery of Potent, Reversible METAP2 Inhibitors Via Fragment Based Drug Discovery and Structure Based Drug Design-Part 1. Bioorg.Med.Chem.Lett. V. 26 2774 2016.
Page generated: Sun Oct 6 01:32:01 2024
ISSN: ESSN 1464-3405 PubMed: 27155900 DOI: 10.1016/J.BMCL.2016.04.073 |
Last articlesZn in 9JPJZn in 9JP7 Zn in 9JPK Zn in 9JPL Zn in 9GN6 Zn in 9GN7 Zn in 9GKU Zn in 9GKW Zn in 9GKX Zn in 9GL0 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |